Exo Therapeutics picks up $25m Series A

Exo Therapeutics Inc, a small molecule drug discovery and development company, has closed $25 million in Series A financing.

Exo Therapeutics Inc, a small molecule drug discovery and development company, has closed $25 million in Series A financing. The investors included Newpath Partners, Novartis Venture Fund, CRV and 6 Dimensions Capital.

Source: Press Release